Collaboration - October 21, 2025
A Nordic model for pandemic preparedness
A new Nordic research network develops models that can estimate how an infection will spread, thereby supporting rapid response during a future pandemic.
Global report - October 13, 2025
AstraZeneca in agreement with US government to lower the cost of medicines
At an event at the White House, AstraZeneca CEO Pascal Soriot joined President Trump and members of his Administration to confirm the company voluntarily met all requests set out in the President’s 31 July letter.
Global report - October 10, 2025
AstraZeneca plans to increase investment and scope of Virginia facility
AstraZeneca will invest USD 4.5 billion in its new manufacturing facility in Virginia, a proposed increase of USD 500 million to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments.
Global report - October 6, 2025
AstraZeneca and Algen enter multi-taget partnership
Algen to receive up to USD 555 million, including upfront, near-term payments, and potential future milestones.
Global report - October 3, 2025
CaixaResearch Institute – A key player in Barcelona’s life science hub
Investment in science drives societal progress. Barcelona has been doing its part for more than two decades and is now demonstrating its commitment with the construction of the CaixaResearch Institute – a center that aspires to become a benchmark in immunological diseases.
Global report - September 30, 2025
New Trump campaign on tariffs shows that the EU’s internal market must be strengthened, states SwedenBIO
President Trump recently announced that trademarked or patented pharmaceutical products will be subject to a 100 percent tariff starting October 1, 2025 – unless the manufacturer establishes a production facility in the United States. The latest move reinforces the uncertainty that the life sciences industry is already experiencing and raises a number of questions about […]
